Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Banu Öztürk
Observed names:
Banu Ozturk,
Banu Oztürk,
Banu ÖZTÜRK,
Ozturk Banu,
Öztürk, Banu
Institutions:
Antalya Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi
Observed institutions:
Selçuk University,
Tokat Gaziosmanpaşa Üniversitesi,
Antalya Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi
ORCID:
0000-0003-0290-8787
Observed ORCID:
0000-0003-0290-8787
OpenAlex ID:
A5101797672
Works
45
Awards
1
Predictive and Prognostic Value of Inflammatory and Nutritional Indexes in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy
2024
·
Mustafa Ozgur Arici
, Derya Kivrak Salim
, et al.
·
Medicina
·
20
Pan-Immune-Inflammation Value as a Novel Prognostic Biomarker for Advanced Pancreatic Cancer
2024
·
Asim Armagan Aydin
, Erkan Kayikcioglu
, et al.
·
Cureus
·
11
Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy
2024
·
Yusuf Ilhan
, Gokhan Ucar
, et al.
·
Expert Opinion on Pharmacotherapy
·
8
Depression and anxiety in oncology nurses.
2018
·
Özge Keskin
, Esin Oktay
, et al.
·
Journal of Clinical Oncology
·
7
Immune-related adverse events as predictors of pathological complete response in early-stage triple-negative breast cancer treated with pembrolizumab
2026
·
Ali Kaan Güren
, Nazım Can Demircan
, et al.
·
Immunotherapy
·
4
Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study
2025
·
Taha Koray Sahin
, Fatih Atalah
, et al.
·
Frontiers in Immunology
·
4
PDF
Novel tumor marker index combining carcinoembryonic antigen and carbohydrate antigen 19-9: New prognostic factor for metastatic colorectal cancer
2025
·
Yusuf Ilhan
, Onur Yazdan Balcik
, et al.
·
World Journal of Gastrointestinal Oncology
·
4
PDF
Pretreatment Lactate Dehydrogenase-to-Albumin Ratio and Clinical Outcomes in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
2026
·
Ahmet Unlu
, Asim Armagan Aydin
, et al.
·
Journal of Clinical Medicine
·
3
PDF
Potential 20-Week Faricimab Dosing in Wet Age-Related Macular Degeneration
2026
·
Aude Ambresin
, Varun Chaudhary
, et al.
·
Ophthalmology Retina
·
3
Pan-Immune-Inflammation Value as a Predictor of Long-Term Outcomes in Patients with Urothelial Carcinoma of the Bladder: A Pilot Study
2025
·
Ali Erhan Eren
, Asim Armagan Aydin
, et al.
·
Current Oncology
·
3
PDF
Impact of Treatment Modalities on Locally Advanced Gastric Cancer—Real-World Data
2025
·
Esma Uguztemur
, Banu Oztürk
·
Current Oncology
·
3
PDF
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis
2026
·
Baris Koksal
, Hasan Cagri Yildirim
, et al.
·
Journal of Clinical Medicine
·
2
PDF
The HALLMOUNT Score: Development of a Novel Multidimensional Prognostic Model for Solid Tumors, with Initial Clinical Application in Grade 4 Adult-Type Diffuse Gliomas
2025
·
Ahmet Unlu
, Asim Armagan Aydin
, et al.
·
Medicina
·
2
PDF
Bridging East and West: Real-World Clinicogenomic Landscape of Metastatic NSCLC in Türkiye
2025
·
Kübra Canaslan
, Emre Eken
, et al.
·
Genes
·
2
PDF
Real‐world comparison of cabozantinib and sunitinib in advanced non‐clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group
2025
·
Gökhan Şahin
, Esmanur Kaplan Tüzün
, et al.
·
International Journal of Cancer
·
2
Platelet-to-Albumin Ratio and Clinical Outcomes in IDH-Wildtype Grade 4 Diffuse Glioma
2026
·
Ozan Deniz Guven
, Asim Armagan Aydin
, et al.
·
Journal of Clinical Medicine
·
1
PDF
Evaluation of the predictive and prognostic performance of the PILE score in metastatic renal cell carcinoma
2026
·
Halil Göksel Güzel
, Asım Armağan Aydın
, et al.
·
Frontiers in Medicine
·
1
PDF
Corneal Epithelial Alterations Associated With Cyclin-Dependent Kinase 4/6 Inhibitor Therapy in Hormone Receptor–Positive Breast Cancer
2026
·
Esra Kızıldag Ozbay
, Banu Ozturk
, et al.
·
American Journal of Ophthalmology
·
1
Extent of Resection and Survival in IDH-Wildtype Glioblastoma: A Dual-Center Retrospective Study
2026
·
Selami Bayram
, Mustafa Serkan Alemdar
, et al.
·
Medicina
·
1
PDF
Durvalumab-Based First-Line Chemoimmunotherapy in Advanced Biliary Tract Cancer: Real-World Outcomes and Prognostic Factors—A Turkish Oncology Group Study
2025
·
Safa Can Efil
, Fatih Kus
, et al.
·
Cancers
·
1
PDF
Is the risk of brain metastasis and prognosis different in HER2-low breast cancer?
2025
·
Yaşar Culha
, Beyza Ünlü
, et al.
·
Clinical & Translational Oncology
·
1
Symptom Reporting Behaviors, Symptom Burden, and Quality of Life in Patients with Hormone Receptor–Positive Breast Cancer Undergoing Adjuvant Endocrine Therapy
2025
·
Ece Ulukal Karanci
, Halil Göksel Güzel
, et al.
·
Current Oncology
·
1
PDF
The Gustave Roussy immune score as a novel biomarker for predicting survival in patients with isocitrate dehydrogenase wild-type glioblastoma treated with the Stupp protocol
2025
·
Asim Armagan Aydin
, Ahmet Unlu
, et al.
·
Expert Review of Anticancer Therapy
·
1
Prognostic Factors and Survival Data of Stage I Lung Cancer: A Single-Center Experience
2025
·
Mustafa Ozgur Arici
, Halil Goksel Guzel
, et al.
·
Journal of Clinical Practice and Research
·
1
PDF
Meme Kanseri ve Moleküler Alt Tiplerinin Menopoz Durumu ve Vücut Kitle İndeksi İle İlişkisi
2022
·
Mehmet İlker TURAN
, Mustafa KARACA
, et al.
·
Akdeniz Medical Journal
·
1
PDF
Show more works
View as search
Works count:
45
Citation count:
90
H-index:
4
I10-index:
2
Year
Topic
Type